skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Treatment Outcome remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes. I: Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA
Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes. I: Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA
Material Type:
Artigo 		Adicionar ao Meu Espaço

Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) lymphocytes. I: Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA

JEFFES, E. W. B. III ; BEAMER, Y. B ; JACQUES, S ; SILBERMAN, R. S ; BHARATHI VAYUVEGULA ; SUDHIR GUPTA ; COSS, J. S ; YAMAMOTO, R. S ; GRANGER, G. A

Journal of neuro-oncology, 1993-02, Vol.15 (2), p.141-155 [Periódico revisado por pares]

Dordrecht: Springer

Texto completo disponível

Citações Citado por
2
Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
Material Type:
Artigo 		Adicionar ao Meu Espaço

Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum

Lund, Lars H. ; Claggett, Brian ; Liu, Jiankang ; Lam, Carolyn S. ; Jhund, Pardeep S. ; Rosano, Giuseppe M. ; Swedberg, Karl ; Yusuf, Salim ; Granger, Christopher B. ; Pfeffer, Marc A. ; McMurray, John J.V. ; Solomon, Scott D.

European journal of heart failure, 2018-08, Vol.20 (8), p.1230-1239 [Periódico revisado por pares]

Oxford, UK: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
3
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial

DeVore, Adam D ; Granger, Bradi B ; Fonarow, Gregg C ; Al-Khalidi, Hussein R ; Albert, Nancy M ; Lewis, Eldrin F ; Butler, Javed ; Piña, Ileana L ; Allen, Larry A ; Yancy, Clyde W ; Cooper, Lauren B ; Felker, G. Michael ; Kaltenbach, Lisa A ; McRae, A. Thomas ; Lanfear, David E ; Harrison, Robert W ; Disch, Maghee ; Ariely, Dan ; Miller, Julie M ; Granger, Christopher B ; Hernandez, Adrian F

JAMA : the journal of the American Medical Association, 2021-07, Vol.326 (4), p.314-323 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
4
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

Oldgren, Jonas ; Budaj, Andrzej ; Granger, Christopher B ; Khder, Yasser ; Roberts, Juliet ; Siegbahn, Agneta ; Tijssen, Jan G.P ; Van de Werf, Frans ; Wallentin, Lars

European heart journal, 2011-11, Vol.32 (22), p.2781-2789 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
5
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial

Lopes, Renato D ; Macedo, Ariane V. S ; de Barros E Silva, Pedro G. M ; Moll-Bernardes, Renata J ; dos Santos, Tiago M ; Mazza, Lilian ; Feldman, André ; D’Andréa Saba Arruda, Guilherme ; de Albuquerque, Denílson C ; Camiletti, Angelina S ; de Sousa, Andréa S ; de Paula, Thiago C ; Giusti, Karla G. D ; Domiciano, Rafael A. M ; Noya-Rabelo, Márcia M ; Hamilton, Alan M ; Loures, Vitor A ; Dionísio, Rodrigo M ; Furquim, Thyago A. B ; De Luca, Fábio A ; dos Santos Sousa, Ítalo B ; Bandeira, Bruno S ; Zukowski, Cleverson N ; de Oliveira, Ricardo G. G ; Ribeiro, Noara B ; de Moraes, Jeffer L ; Petriz, João L. F ; Pimentel, Adriana M ; Miranda, Jacqueline S ; de Jesus Abufaiad, Bárbara E ; Gibson, C. Michael ; Granger, Christopher B ; Alexander, John H ; de Souza, Olga F

JAMA : the journal of the American Medical Association, 2021-01, Vol.325 (3), p.254-264 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
6
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Material Type:
Artigo 		Adicionar ao Meu Espaço

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Ariti, Cono A., MSc ; Cleland, John G.F., MD ; Pocock, Stuart J., PhD ; Pfeffer, Marc A., MD, PhD ; Swedberg, Karl, MD, PhD ; Granger, Christopher B., MD ; McMurray, John J.V., MD ; Michelson, Eric L., MD ; Östergren, Jan, MD, PhD ; Yusuf, Salim, MD, DPhil

The American heart journal, 2011-11, Vol.162 (5), p.900-906 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Healey, Jeff S. ; Lopes, Renato D. ; Granger, Christopher B. ; Alings, Marco ; Rivard, Lena ; McIntyre, William F. ; Atar, Dan ; Birnie, David H. ; Boriani, Giuseppe ; Camm, A. John ; Conen, David ; Erath, Julia W. ; Gold, Michael R. ; Hohnloser, Stefan H. ; Ip, John ; Kautzner, Josef ; Kutyifa, Valentina ; Linde, Cecilia ; Mabo, Philippe ; Mairesse, Georges ; Benezet Mazuecos, Juan ; Cosedis Nielsen, Jens ; Philippon, Francois ; Proietti, Marco ; Sticherling, Christian ; Wong, Jorge A. ; Wright, David J. ; Zarraga, Ignatius G. ; Coutts, Shelagh B. ; Kaplan, Andrew ; Pombo, Marta ; Ayala-Paredes, Felix ; Xu, Lizhen ; Simek, Kim ; Nevills, Sandra ; Mian, Rajibul ; Connolly, Stuart J.

The New England journal of medicine, 2024-01, Vol.390 (2), p.107-117 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

Easton, J Donald, Dr ; Lopes, Renato D, MD ; Bahit, M Cecilia, MD ; Wojdyla, Daniel M, MS ; Granger, Christopher B, MD ; Wallentin, Lars, MD ; Alings, Marco, MD ; Goto, Shinya, MD ; Lewis, Basil S, MD ; Rosenqvist, Mårten, MD ; Hanna, Michael, MD ; Mohan, Puneet, MD ; Alexander, John H, MD ; Diener, Hans-Christoph, MD

Lancet neurology, 2012-06, Vol.11 (6), p.503-511 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial

Newby, L Kristin, Prof ; Marber, Michael S, Prof ; Melloni, Chiara, MD ; Sarov-Blat, Lea, PhD ; Aberle, Laura H, BSPH ; Aylward, Philip E, Prof ; Cai, Gengqian, PhD ; de Winter, Robbert J, Prof ; Hamm, Christian W, Prof ; Heitner, John F, MD ; Kim, Raymond, Prof ; Lerman, Amir, MD ; Patel, Manesh R, MD ; Tanguay, Jean-Francois, Prof ; Lepore, John J, MD ; Al-Khalidi, Hussein R, PhD ; Sprecher, Dennis L, MD ; Granger, Christopher B, Prof

The Lancet (British edition), 2014-09, Vol.384 (9949), p.1187-1195 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)

FLAKER, Greg ; LOPES, Renato D ; VINEREANU, Dragos ; HUSTED, Steen ; HARJOLA, Veli Pekka ; ROSENQVIST, Marten ; ALEXANDER, John H ; GRANGER, Christopher B ; AL-KHATIB, Sana M ; HERMOSILLO, Antonio G ; HOHNLOSER, Stefan H ; TINGA, Brian ; JUN ZHU ; MOHAN, Puneet ; GARCIA, David ; BARTUNEK, Jozef

Journal of the American College of Cardiology, 2014-03, Vol.63 (11), p.1082-1087 [Periódico revisado por pares]

New York, NY: Elsevier

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (134)

Data de Publicação 

De até
Refinar
  1. Antes de1999  (18)
  2. 1999Até2004  (26)
  3. 2005Até2010  (34)
  4. 2011Até2017  (38)
  5. Após 2017  (21)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.